TIMED-BIORESORBABLE RADIOSEEDS FOR PROSTATE CANCER

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$108,863.00
Award Year:
2001
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
53782
Agency Tracking Number:
1R43CA086567-01A1
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
BOX 1726, 3601 EQUESTRIAN DR, WEST RICHLAND, WA, 99352
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
YONGREN PENG
() -
Business Contact:
(509) 627-2049
CHERRYLEI@AOL.COM
Research Institute:
n/a
Abstract
Radioisotopes used for prostate cancer treatment are predominately photon/gamma-emitters (I-125, Pd-103, Ir-192). Both temporary and permanent gamma-emitting radioseeds have gained acceptance for interstitial implantation in the prostate. Due to greater tissue penetration, however, gamma radiation can cause side effects in the patient such as gastrointestinal discomfort, can cause damage to healthy tissues outside the prostate, and can be hazardous to hospital personnel and family members. The objective of this Phase I research is to demonstrate the feasibility of using timed-bioresorbable glass matrices to encapsulate high energy, beta-emitting radioisotopes such as Y-90. Ideally, seeds from such glasses will not leak radioactivity within 10 half-lives, and will be completely bioresorbed at a predetermined rate. Timed-bioresorbable radioseeds have the advantages of (a) simple outpatient implantation procedures; (b)sparing healthy tissue while delivering a high dose to the tumor; and (c) minimal or no health hazards or side effects, since all of the beta energy is deposited within 8-9 mm in tissue. In addition, chemoprevention agents can be incorporated into the timed-bioresorbable matrix so that their release over time will help to prevent the reoccurrence of the cancer. If successful, timed-bioresorbable glass radioseeds will be a low cost alternative to permanent seeds, and will positively impact radiation therapy of prostate and other cancers. PROPOSED COMMERCIAL APPLICATIONS: Bioresorbable radioseeds hold a great deal of promise for the treatment of solid tumors and for effecting a variety of other localized radiation therapies. In addition, the bioresorbable seeds would be capable of delivering chemoprevention agents to the site of the tumor as on-going clinical trials show such agents to be of value.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government